top of page

COVID-19 highlights the acute need for non-invasive, point-of-care, remote monitoring

hemodynamic measurement solutions. Find out how CPS meets the need.

Sensydia in the news

June 29, 2026

A New Reimbursement Pathway for Non-invasive Hemodynamic Assessment

As of July 1, 2026, a new Category III CPT® code 1036T is effective for non-invasive hemodynamic assessment. The code describes a single assessment that measures pulmonary pressures and ejection fraction when performed, through passively acquired acoustic and electrical signals, applies augmentative algorithmic analysis, and produces a clinical report that a physician or qualified health care professional reviews, interprets, and integrates into care.

CPT® code 1036T for non-invasive hemodynamic assessment.

CPT® code 1036T for non-invasive hemodynamic assessment.

A New Reimbursement Pathway for Non-invasive Hemodynamic Assessment

Sensydia Announces American Medical Association Category III CPT® Code for Noninvasive AI Hemodynamic Assessment

Sensydia Announces American Medical Association Category III CPT® Code for Noninvasive AI Hemodynamic Assessment

Sensydia Announces American Medical Association Category III CPT® Code for Noninvasive AI Hemodynamic Assessment

Sensydia Awarded Second Phase of $3M NIH Grant Award to Demonstrate Clinical Utility of Cardiac Performance System (CPS™)

Sensydia Awarded Second Phase of $3M NIH Grant Award to Demonstrate Clinical Utility of Cardiac Performance System (CPS™)

Sensydia Awarded Second Phase of $3M NIH Grant Award to Demonstrate Clinical Utility of Cardiac Performance System (CPS™)

Rusty Page appointed President and Chief Operating Officer of Sensydia.

Rusty Page appointed President and Chief Operating Officer of Sensydia.

Sensydia Appoints Rusty Page as President and Chief Operating Officer to Support Growth and Commercialization of the Cardiac Performance System (CPS™)

Sensydia’s Cardiac Performance System (CPS™) is designed for fast, safe, and non-invasive cardiac performance assessment that can be performed almost anywhere, avoiding the need to visit a catheterization lab. Source: Sensydia.

Sensydia’s Cardiac Performance System (CPS™) is designed for fast, safe, and non-invasive cardiac performance assessment that can be performed almost anywhere, avoiding the need to visit a catheterization lab. Source: Sensydia.

Sensydia Announces First Patient Enrolled in Pivotal Study of Non-Invasive Cardiac Performance System (CPS™)

Clinical data presented at ACC 2025 shows Sensydia CPS™ provides accurate assessment of mean pulmonary artery pressure non-invasively

Clinical data presented at ACC 2025 shows Sensydia CPS™ provides accurate assessment of mean pulmonary artery pressure non-invasively

Clinical data presented at ACC 2025 shows Sensydia CPS™ provides accurate assessment of mean pulmonary artery pressure non-invasively

bottom of page